OMNIAB, INC. Operating Income
OMNIAB, INC. (OABI) reported Operating Income of -$6.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- OMNIAB, INC. operating income (loss) for the quarter ending 2026-06-30 was -$6.64M.
- OMNIAB, INC. operating income (loss) for the quarter ending 2026-03-31 was -$7.83M.
- OMNIAB, INC. operating income (loss) for the quarter ending 2025-12-31 was -$15.77M.
- OMNIAB, INC. operating income (loss) for the quarter ending 2025-09-30 was -$18.14M.
- OMNIAB, INC. operating income (loss) for fiscal 2025 was -$68.97M.
- OMNIAB, INC. operating income (loss) for fiscal 2024 was -$74.50M.
- OMNIAB, INC. operating income (loss) for fiscal 2023 was -$69.42M.
- OMNIAB, INC. operating income (loss) for fiscal 2022 was -$26.65M.
| Period end | Operating Income (Loss) 2 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 5 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 8 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.64M 10-Q · filed 2026-08-06 | -$14.47M 10-Q · filed 2026-08-06 | -$30.23M derived: sum of 3 quarters · filed 2026-08-06 | -$48.37M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2026-03-31 | -$7.83M 10-Q · filed 2026-05-07 | -$23.59M derived: sum of 2 quarters · filed 2026-05-07 | -$41.73M derived: sum of 3 quarters · filed 2026-05-07 | -$57.95M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2025-12-31 | -$15.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$33.91M derived: sum of 2 quarters · filed 2026-03-04 | -$50.13M derived: sum of 3 quarters · filed 2026-08-06 | -$68.97M 10-K · filed 2026-03-04 | ||||||
| 2025-09-30 | -$18.14M 10-Q · filed 2025-11-04 | -$34.36M derived: sum of 2 quarters · filed 2026-08-06 | -$53.20M 10-Q · filed 2025-11-04 | -$69.08M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2025-06-30 | -$16.22M 10-Q · filed 2026-08-06 | -$35.06M 10-Q · filed 2026-08-06 | -$50.94M derived: sum of 3 quarters · filed 2026-08-06 | -$70.71M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2025-03-31 | -$18.84M 10-Q · filed 2026-05-07 | -$34.72M derived: sum of 2 quarters · filed 2026-05-07 | -$54.49M derived: sum of 3 quarters · filed 2026-05-07 | -$70.79M derived: sum of 4 quarters · filed 2026-05-07 | ||||||
| 2024-12-31 | -$15.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$35.64M derived: sum of 2 quarters · filed 2026-03-04 | -$51.95M derived: sum of 3 quarters · filed 2026-03-04 | -$74.50M 10-K · filed 2026-03-04 | ||||||
| 2024-09-30 | -$19.76M 10-Q · filed 2025-11-04 | -$36.07M derived: sum of 2 quarters · filed 2025-11-04 | -$58.62M 10-Q · filed 2025-11-04 | -$79.83M derived: sum of 4 quarters · filed 2025-11-04 | ||||||
| 2024-06-30 | -$16.30M 10-Q · filed 2025-08-06 | -$38.86M 10-Q · filed 2025-08-06 | -$60.06M derived: sum of 3 quarters · filed 2025-08-06 | -$80.38M derived: sum of 4 quarters · filed 2025-08-06 | ||||||
| 2024-03-31 | -$22.55M 10-Q · filed 2025-05-08 | -$43.76M derived: sum of 2 quarters · filed 2025-05-08 | -$64.07M derived: sum of 3 quarters · filed 2025-05-08 | -$83.52M derived: sum of 4 quarters · filed 2025-05-08 | ||||||
| 2023-12-31 | -$21.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$41.52M derived: sum of 2 quarters · filed 2025-03-18 | -$60.97M derived: sum of 3 quarters · filed 2025-03-18 | -$69.42M 10-K · filed 2025-03-18 | ||||||
| 2023-09-30 | -$20.32M 10-Q · filed 2024-11-12 | -$39.76M derived: sum of 2 quarters · filed 2024-11-12 | -$48.21M 10-Q · filed 2024-11-12 | -$39.16M derived: sum of 4 quarters · filed 2024-11-12 | ||||||
| 2023-06-30 | -$19.45M 10-Q · filed 2024-08-08 | -$27.90M 10-Q · filed 2024-08-08 | -$18.85M derived: sum of 3 quarters · filed 2024-08-08 | -$33.76M derived: sum of 4 quarters · filed 2024-08-08 | ||||||
| 2023-03-31 | -$8.45M 10-Q · filed 2024-05-09 | $597.00K derived: sum of 2 quarters · filed 2024-05-09 | -$14.31M derived: sum of 3 quarters · filed 2024-05-09 | -$26.88M derived: sum of 4 quarters · filed 2024-05-09 | ||||||
| 2022-12-31 | $9.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$5.86M derived: sum of 2 quarters · filed 2024-03-25 | -$18.43M derived: sum of 3 quarters · filed 2024-03-25 | -$26.65M 10-K · filed 2024-03-25 | ||||||
| 2022-09-30 | -$14.91M 10-Q · filed 2023-11-09 | -$2.34M 10-Q · filed 2022-11-10 | -$27.48M derived: sum of 2 quarters · filed 2023-11-09 | -$35.70M 10-Q · filed 2023-11-09 | -$8.74M 10-Q · filed 2022-11-10 | |||||
| 2022-06-30 | -$12.57M 10-Q · filed 2023-08-10 | -$2.58M 10-Q · filed 2022-08-12 | -$20.79M 10-Q · filed 2023-08-10 | -$6.40M 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | -$8.22M 10-Q · filed 2023-05-11 | -$3.82M 10-Q · filed 2022-05-20 | ||||||||
| 2021-12-31 | -$35.61M 10-K · filed 2023-03-30 | |||||||||
| 2021-09-30 | -$170.58K 10-Q · filed 2022-11-10 | -$172.76K derived: sum of 2 quarters · filed 2022-11-10 | -$180.55K 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | -$2.19K 10-Q · filed 2022-08-12 | -$9.97K 10-Q · filed 2022-08-12 | ||||||||
| 2021-03-31 | -$7.79K 10-Q · filed 2022-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |